Key Dates

Related Announcements

PAR-20-115 - “Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase 3 - Transitional Centers (P30 Clinical Trial Optional)”

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to announce updated instructions for demonstrating the eligibility of the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) in PAR-20-115 “Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase 3 - Transitional Centers (P30 Clinical Trial Optional)” by providing information on current and pending support.

The following section of the FOA is revised accordingly:

Part 2. Section IV. Application and Submission Information

2. Content and Form of Application Submission

Overall Component

Research & Related Other Project Information (Overall)

Current language:

Follow standard instructions.

Facilities and Other Resource: Applications must briefly describe the institutional environment and resources available to investigators and indicate how prior COBRE support has improved facilities or made available new and collaborative resources (e.g., laboratory facilities, patient populations, laboratory space and personnel).

Other Attachments: A list of all publications produced in COBRE Phases 1 and 2 must be included here.

Revised language in italics:

Follow standard instructions, with the following additional instructions.

Facilities and Other Resource: Applications must briefly describe the institutional environment and resources available to investigators and indicate how prior COBRE support has improved facilities or made available new and collaborative resources (e.g., laboratory facilities, patient populations, laboratory space and personnel).

Other Attachments: The application must contain the following attachments:

COBRE-related Publications: The application must include an attachment titled "COBRE-related Publications" that contains a list of all publications produced in COBRE Phases 1 and 2.

Current and Pending Support: The application must include an attachment titled “Current and Pending Support” with the following information about all current and pending grants that support the PD/PI’s research program:

• Project Number
• Source of Funding and Title of the Project (or Subproject)
• Role on the Project and Level of Effort (in calendar-months)
• Dates of Approved/Proposed Project
• Annual Direct Costs
• Project Goal

Applications missing these attachments for each PD/PI will be considered incomplete and will be withdrawn without review.

Part 2. Section VI. Award Administration Information

1. Award Notices

Prior Approval of Pilot Projects

Current language:

Awardee-selected projects require prior approval by NIH prior to initiation.

Prior to the commencement of any Pilot Project, the following documentation must be submitted to NIGMS staff for administrative review (see Notice NOT-GM-14-111 for details):

Using PHS398 forms and instructions, only the following sections need to be submitted:

• Face Page (signed by institutional signing official)
• Project Summary (Page 2)
• Research Strategy Section

Revised language in italics:

Awardee-selected projects require prior approval by NIH prior to initiation.

Prior to the commencement of any Pilot Project, the following documentation must be submitted to NIGMS staff for administrative review:

Using PHS398 forms and instructions, only the following sections need to be submitted:

• Face Page (signed by institutional signing official)
• Project Summary (Page 2)
• Biographical Sketch
• Research Strategy Section

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Zuzana Justinova, M.D., Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email:[email protected]